1992 - Fellow of American Physical Society (APS) Citation For pioneering experimental research on ion Bernstein waves and their applications to plasma heating
Her main research concerns Cancer research, Angiogenesis, Neovascularization, Vascular endothelial growth factor and Pathology. Her research integrates issues of Cancer, Protein kinase B, Tyrosine kinase, Gefitinib and Lung cancer in her study of Cancer research. As a member of one scientific family, she mostly works in the field of Angiogenesis, focusing on Cytokine and, on occasion, Proinflammatory cytokine.
Her work deals with themes such as Stromal cell, Inflammation, Endothelium, Interleukin 13 and In vivo, which intersect with Neovascularization. Her Vascular endothelial growth factor study integrates concerns from other disciplines, such as Tumor necrosis factor alpha and Basic fibroblast growth factor. Her Pathology research incorporates themes from Metastasis, Macrophage and Tumor growth.
Mayumi Ono mainly investigates Cancer research, Angiogenesis, Molecular biology, Cell culture and Internal medicine. The various areas that Mayumi Ono examines in her Cancer research study include Cancer cell, Cancer, Epidermal growth factor receptor, Gefitinib and Protein kinase B. Her Angiogenesis research is multidisciplinary, incorporating perspectives in Endothelial stem cell, Vascular endothelial growth factor A, Vascular endothelial growth factor and Pathology.
Her Molecular biology study combines topics in areas such as Biochemistry, Mutant, Transfection, Escherichia coli and Gene. Her research investigates the connection with Cell culture and areas like In vitro which intersect with concerns in In vivo. Her study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology.
Her scientific interests lie mostly in Cancer research, Cancer, Cancer cell, Erlotinib and Epidermal growth factor receptor. Her Cancer research research integrates issues from Protein kinase B, Gene knockdown, Internal medicine, Lung cancer and Gefitinib. Her study in Cancer is interdisciplinary in nature, drawing from both PI3K/AKT/mTOR pathway and Pathology.
Her Cancer cell research includes elements of Angiogenesis, Cellular differentiation, Cell growth, Cell biology and Cell cycle. Her work investigates the relationship between Angiogenesis and topics such as Vascular endothelial growth factor that intersect with problems in Tumor necrosis factor alpha. Her Erlotinib research includes themes of Tyrosine kinase, Molecular biology and PTEN.
Her primary areas of investigation include Cancer research, Epidermal growth factor receptor, Lung cancer, Gefitinib and Pathology. Her Cancer research research incorporates themes from Cell culture, Cancer cell, Signal transduction, Receptor tyrosine kinase and Erlotinib. Her study looks at the intersection of Lung cancer and topics like Mutation with Carcinoma.
Gefitinib is a subfield of Internal medicine that Mayumi Ono explores. Her research in Pathology intersects with topics in Cancer, Angiogenesis, Neovascularization and Tumor-associated macrophage. Her Angiogenesis research focuses on Vascular endothelial growth factor A and how it relates to Stromal cell, Lymphangiogenesis and Interleukin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Interleukin-17 promotes angiogenesis and tumor growth.
Muneo Numasaki;Jun Ichi Fukushi;Mayumi Ono;Satwant K. Narula.
Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis.
Shigeo Yoshida;Mayumi Ono;Tadahisa Shono;Hiroto Izumi.
Molecular and Cellular Biology (1997)
Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells POSSIBLE ROLES OF SP-1
Masahiro Ryuto;Mayumi Ono;Hiroto Izumi;Shigeo Yoshida.
Journal of Biological Chemistry (1996)
ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase.
Akira Hirata;Soh-ichiro Ogawa;Takuro Kometani;Takashi Kuwano.
Cancer Research (2002)
Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL‐1α
Hitoe Torisu;Mayumi Ono;Hiromaro Kiryu;Masutaka Furue.
International Journal of Cancer (2000)
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas
Miguel Taron;Yukito Ichinose;Rafael Rosell;Tony Mok.
Clinical Cancer Research (2005)
Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.
Ken Samoto;Kiyonobu Ikezaki;Mayumi Ono;Tadahisa Shono.
Cancer Research (1995)
Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs.
Mayumi Ono;Michihiko Kuwano.
Clinical Cancer Research (2006)
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
Michela Garofalo;Giulia Romano;Gianpiero Di Leva;Gerard Nuovo.
Nature Medicine (2012)
Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy
Cancer Science (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: